The Bismarck Parkinson’s Support Group will have a guest speaker at our next monthly support group meeting on Thursday, June 9 at 3 p.m. in Boniface Hall, CHI St. Alexius Health, 900 East Broadway, Bismarck ND. The presentation is free and open to the public, registration is not required.
Chris Sheridan, BSN, RN is a Duopa RN Specialist with AbbVie Biopharmaceutical Company in Chicago IL. He has been an RN for over 20 years (ICU, Pediatrics, and Research) and has spent the last 16 years working with people with Parkinson’s disease, to educate patients and their caregivers. His work with PD started at Boston University Medical Center where, from 2000 to 2005, he ran the Parkinson’s Day Program and Deep Brain Stimulation (DPS) Program. In 2005, he moved back to Milwaukee, WI and for the next 10 years managed and coordinated the Parkinson’s and Movement Disorder Program at Froedtert and the Medical College of Wisconsin. This included the DBS Program and Duopa therapy, both treatments for more advanced Parkinson’s disease. Following his passion for working with people with PD, he made the move to Abbvie at the end of 2015, to educate patients and their caregivers about Duopa.
Duopa therapy is a prescription medicine used for treatment of motor fluctuations in advanced Parkinson’s disease. Duopa is not a pill. It’s a gel form, called a suspension, of carbidopa and levodopa. Duopa is delivered continuously by a pump into the intestines for up to 16 hours daily.
Chris’ job as a Duopa RN Specialist with Abbvie, involves talking to Parkinson’s support groups and presenting a program call the “Patient Partner Program: Getting to know Duopa.” The presentation includes an introduction to Duopa therapy, how Duopa is used, safety information (possible side effects) and what a “day in the life” might look like for a person using Duopa. Chris will be accompanied by a patient who is on Duopa therapy. The Patient Partner, an unpaid volunteer, is a person with Parkinson’s disease and he/she shares a story of his/her journey with PD and experience with Duopa.